ClinicalTrialsFinder

Primary Glioblastoma Multiforme Clinical Trials in Cambridge

1 recruitingCambridge, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca180 enrolled12 locationsNCT03423628